Distalmotion

Distalmotion develops the DEXTER Robotic Surgery System, a platform for minimally invasive surgery. The company states that the system is designed to fit into existing operating-room workflows so that more surgeons and sites of care can use robotic surgery.

Its customers are hospitals, outpatient facilities and surgeons. The website describes separate offerings for surgeons and for hospitals, and the company sells the system as a medical device. The US indications listed on the site cover laparoscopic inguinal and ventral hernia repair, cholecystectomy, total benign hysterectomy with salpingo-oophorectomy, and sacrocolpopexy, for adult patients aged 22 and older. The CE mark was received in 2020 for urology, gynecology and general surgery.

Distalmotion was founded in 2012 as a spin-off from the Robotics Lab of EPFL in Lausanne. The website gives its headquarters as Lausanne, Switzerland, and the Swiss legal address is in Epalinges. The company reports more than 150 members from over 25 nationalities, and its open roles include US commercial sales positions and engineering roles in Epalinges.

Product: DEXTER Robotic Surgery System for minimally invasive surgical procedures.